Innovent Biologics (HK:1801) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Innovent Biologics, a biopharmaceutical company, has announced changes to its board committees, effective August 30, 2024. Dr. De-Chao Michael Yu has transitioned from chairman to member of the Nomination Committee, stepping down from the Remuneration Committee. Mr. Shuyun Chen moves from member to chairman of the Nomination Committee and joins the Audit Committee.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.
